Philip C. Familletti

1.7k total citations
24 papers, 1.4k citations indexed

About

Philip C. Familletti is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Philip C. Familletti has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Philip C. Familletti's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Immune Cell Function and Interaction (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Philip C. Familletti is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Immune Cell Function and Interaction (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Philip C. Familletti collaborates with scholars based in United States, Switzerland and Poland. Philip C. Familletti's co-authors include Sidney Pestka, David H. Presky, Sara Rubinstein, Maurice K. Gately, A S Stern, Frank Podlaski, Daisy Carvajal, Silke Gillessen, Ueli Gubler and Ping Ling and has published in prestigious journals such as Nature, Science and Nature Biotechnology.

In The Last Decade

Philip C. Familletti

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip C. Familletti United States 12 799 525 281 269 180 24 1.4k
Andrea Woods United States 14 1.2k 1.5× 383 0.7× 255 0.9× 389 1.4× 160 0.9× 19 1.7k
Ole Werdelin Denmark 22 967 1.2× 652 1.2× 240 0.9× 345 1.3× 80 0.4× 76 1.6k
Kenneth LeClair United States 19 1.1k 1.3× 572 1.1× 307 1.1× 230 0.9× 71 0.4× 23 1.7k
Barbara Johnson United States 15 1.2k 1.5× 584 1.1× 242 0.9× 374 1.4× 109 0.6× 25 2.0k
Randall N. Knibbs United States 15 652 0.8× 616 1.2× 260 0.9× 147 0.5× 355 2.0× 25 1.2k
Arthur K. Kimura United States 19 690 0.9× 452 0.9× 198 0.7× 289 1.1× 43 0.2× 41 1.2k
J H Freed United States 20 903 1.1× 473 0.9× 95 0.3× 353 1.3× 58 0.3× 35 1.4k
Reuven Laskov Israel 21 644 0.8× 1.0k 2.0× 177 0.6× 692 2.6× 67 0.4× 74 1.8k
Horacio M. Serra Argentina 19 1.2k 1.5× 612 1.2× 259 0.9× 374 1.4× 99 0.6× 72 1.9k
David J. Flavell United Kingdom 22 564 0.7× 452 0.9× 276 1.0× 206 0.8× 65 0.4× 56 1.3k

Countries citing papers authored by Philip C. Familletti

Since Specialization
Citations

This map shows the geographic impact of Philip C. Familletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Familletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Familletti more than expected).

Fields of papers citing papers by Philip C. Familletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Familletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Familletti. The network helps show where Philip C. Familletti may publish in the future.

Co-authorship network of co-authors of Philip C. Familletti

This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Familletti. A scholar is included among the top collaborators of Philip C. Familletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Familletti. Philip C. Familletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gately, Maurice K., Daisy Carvajal, Suzanne E. Connaughton, et al.. (1996). Interleukin‐12 Antagonist Activity of Mouse Interleukin‐12 p40 Homodimer in Vitro and in Vivo. Annals of the New York Academy of Sciences. 795(1). 1–12. 118 indexed citations
2.
Gillessen, Silke, Daisy Carvajal, Ping Ling, et al.. (1995). Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist. European Journal of Immunology. 25(1). 200–206. 391 indexed citations
3.
Graves, Bradford, R. Crowther, John M. Rumberger, et al.. (1994). Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature. 367(6463). 532–538. 333 indexed citations
4.
Levin, Wayne, et al.. (1992). Purification of recombinant human secretory phospholipase A2 (Group II) produced in long-term immobilized cell culture. Protein Expression and Purification. 3(1). 27–35. 10 indexed citations
5.
6.
7.
Weber, David V., et al.. (1988). Medium-scale ligand-affinity purification of two soluble forms of human interleukin-2 receptor. Journal of Chromatography B Biomedical Sciences and Applications. 431(1). 55–63. 17 indexed citations
8.
Familletti, Philip C. & Judith Wardwell-Swanson. (1988). A Novel Approach to Bioassays. Bio/Technology. 6(10). 1169–1172. 15 indexed citations
9.
Bailon, Pascal, David V. Weber, Joan Fredericks, et al.. (1987). Receptor-Affinity Chromatography: A One-Step Purification for Recombinant Interleukin-2. Nature Biotechnology. 5(11). 1195–1198. 31 indexed citations
10.
Pan, Yu‐Ching E., et al.. (1987). Structural characterization of human interferon gamma Heterogeneity of the carboxyl terminus. European Journal of Biochemistry. 166(1). 145–149. 30 indexed citations
11.
Moore, Malcolm A.S., C Bona, W R Benjamin, et al.. (1987). Inhibition of spontaneous proliferation of human leukemic B cells from patients with chronic lymphocytic leukemia by anti-μ antibodies. Clinical Immunology and Immunopathology. 44(3). 371–380. 4 indexed citations
12.
Familletti, Philip C., et al.. (1986). [8] Production of human immune interferon from leukocytes cocultured with exogenous cells. Methods in enzymology on CD-ROM/Methods in enzymology. 119. 63–69. 2 indexed citations
13.
Wolfe, Richard, et al.. (1984). Isolation of proteins from crude mixtures with silica and silica-based adsorbents. Journal of Chromatography A. 296. 277–284. 2 indexed citations
14.
Weissbach, Herbert, David V. Goeddel, Shuichiro Maeda, et al.. (1981). In vitro synthesis of biologically active human leukocyte interferon directed by recombinant plasmid DNA. Archives of Biochemistry and Biophysics. 210(1). 417–419. 2 indexed citations
15.
Waldman, Alan A., Robert Scott Miller, Philip C. Familletti, Sara Rubinstein, & Sidney Pestka. (1981). [5] Induction and production of interferon with human leukocytes from normal donors with the use of Newcastle disease virus. Methods in enzymology on CD-ROM/Methods in enzymology. 78(Pt A). 39–44. 10 indexed citations
16.
Familletti, Philip C. & Sidney Pestka. (1981). Cell Cultures Producing Human Interferon. Antimicrobial Agents and Chemotherapy. 20(1). 1–4. 9 indexed citations
17.
Familletti, Philip C., Sara Rubinstein, & Sidney Pestka. (1981). [56] A convenient and rapid cytopathic effect inhibition assay for interferon. Methods in enzymology on CD-ROM/Methods in enzymology. 78(Pt A). 387–394. 178 indexed citations
18.
Familletti, Philip C.. (1981). [43] Use of commercial sources of Newcastle disease virus: Production, purification, and characterization. Methods in enzymology on CD-ROM/Methods in enzymology. 78(Pt A). 305–309. 2 indexed citations
19.
Jilka, Robert L., Philip C. Familletti, & Sidney Pestka. (1979). Synthesis and processing of the mouse MOPC-321 k chain in Xenopus laevis oocytes. Archives of Biochemistry and Biophysics. 192(1). 290–295. 10 indexed citations
20.
Rubinstein, Menachem, Sara Rubinstein, Philip C. Familletti, et al.. (1978). Human Leukocyte Interferon Purified to Homogeneity. Science. 202(4374). 1289–1290. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Woods Breakdown of academic impact, for papers by Ole Werdelin Breakdown of academic impact, for papers by Kenneth LeClair Breakdown of academic impact, for papers by Barbara Johnson Breakdown of academic impact, for papers by Randall N. Knibbs Breakdown of academic impact, for papers by Arthur K. Kimura Breakdown of academic impact, for papers by J H Freed Breakdown of academic impact, for papers by Reuven Laskov Breakdown of academic impact, for papers by Horacio M. Serra Breakdown of academic impact, for papers by David J. Flavell
Rankless by CCL
2026